Showing results (1021-1030 of 15,775) with videos related to

Sort By:
Pageof 1,578
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria and Listeria monocytogenesL Martínez-Martínez, A Pascual, A I Suárez, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Serum bactericidal activity of levofloxacin against Streptococcus pneumoniaeP M Shah
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Levofloxacin: serum bactericidal activity against methicillin-resistant Staphylococcus aureus isolatesC Muller-Serieys, D Decré, C Benoit, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Bactericidal activity of levofloxacin against Streptococcus pneumoniae in an in-vitro model simulating serum pharmacokinetic parametersP M Shah, R Schwärzel
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristicsE B Chaïbi, D Sirot, G Paul, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1999
A review of the role of antibiotic policies in the control of antibiotic resistanceI M Gould
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitisM M Wasilewski, D Johns, G D Sides
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Correlation between genotype and beta-lactamases of clinical and environmental strains of Stenotrophomonas maltophiliaM Denton, V Keer, P M Hawkey
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococciC von Eiff, G Peters
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticumE Dósa, E Nagy, W Falk, et al.
Pageof 1,578